Hetero enters into agreement with Gilead to manufacture and distribute multi drug-resistant HIV
- Posted on October 3, 2024
- By Financial Express
- 6 Views
Hetero enters into agreement with Gilead to manufacture and distribute multi drug-resistant HIV
Lenacapavir was approved for use in HIV-positive adults with multi-drug resistance by the European Union in August 2022 and received U.S. FDA approval in December 2022.
